Acalabrutinib Real World Italian obSErvational Study -ARISE

Clinical trial NCT06205498 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06205498
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2023-08-08
Primary completion: 2027-04-30
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.